Center for Applied Immunology and Pathological Processes
Center for Applied Immunology and Pathological Processes
批准号:
10569050
负责人:
ANDREW D YUROCHKO
金额:
$212.15万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-03-01 至 2026-02-28
关键词:
AddressAdultAdvisory CommitteesAffectAgeAntibioticsAntiviral resistanceAreaArthritisBacterial InfectionsBasic ScienceBone remodelingCardiovascular systemCell NucleusCell physiologyCellsCenters of Research ExcellenceCessation of lifeChlamydiaChronicClinicalCollaborationsCommunicable DiseasesCore FacilityDataDevelopmentDisciplineDiseaseEmbryonic DevelopmentEnvironmentEquipmentFacultyFosteringFoundationsFunctional disorderFundingFutureGoalsGonorrheaGrantGrowthGrowth and Development functionHIVHandHealthHealth SciencesHealthcare SystemsHeart DiseasesHomeHost DefenseHumanHuman ResourcesHyperactivityImmuneImmune responseImmune systemImmunologyImmunophenotypingImmunotherapyIndividualInfectionInfection ControlInfectious AgentInflammatoryInfrastructureInnate Immune ResponseInternationalLeadershipLouisianaMalignant NeoplasmsMentorsMentorshipMissionModelingMolecularNeonatalPathogenesisPathologic ProcessesPathologyPlayPreventionProcessProgram DevelopmentResearchResearch InfrastructureResearch PersonnelResourcesRestRoleSchoolsScienceScientific Advances and AccomplishmentsSexually Transmitted DiseasesSite-Directed MutagenesisSpecialistSyphilisTeacher Professional DevelopmentTechniquesTherapeutic InterventionTrainingTraining ProgramsUnited StatesUniversitiesViralVirus Diseasesadaptive immune responsecell growthchronic inflammatory diseaseeffective therapyexperiencefaculty researchhuman diseaseimmune functionimmunopathologyimprovedinsightmembermortalitynegative affectnovel therapeuticspathogenpathogenic bacteriapathogenic virusprogramsrecruitresponsestatisticssuccesssynergismtooltranslational potentialtumorwound healing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
A properly functioning and effective immune system is needed to control infection by bacterial, viral and
other pathogen invaders, growth of aberrant cells, as well as for proper embryonic development, wound healing,
bone remodeling, and other normal homeostatic processes. Thus, understanding the innate and adaptive
immune responses and how abnormalities affect human health in chronic inflammatory conditions, during
neonatal development and how infectious diseases and cancers subvert or alter these responses is critical to
improving our health, not only in the United States, but globally. Closer to home, this unfortunately remains
especially true in the state of Louisiana, which ranks near the bottom in many national health studies. For
example, human immunodeficiency virus (HIV) age adjusted deaths in the state are more than double the
national average, while the state ranks in the top 5 in infections with the sexually transmitted diseases, Syphilis,
Gonorrhea and Chlamydia. In addition, as is documented for many states in the south, Louisiana has some of
the highest rates of arthritis (affecting ~1 in 4 adults in the state), heart disease and cardiovascular deaths
(ranked 46/50 and 48/50 respectively), and cancer-related mortality rates (15-20% higher than the national
average) in the nation. These glaring statistics support the need for additional understanding of the pathogenesis
of these diseases and new options for therapeutic interventions. One common theme among these different
diseases is an aberrant immune response and resulting immunopathologies. Thus, we propose a better
understanding of how aberrations in the immune system result in disease is needed. We propose that a targeted
growth of an immunology-centric center on our campus at LSUHSC-S will positively influence the health of our
citizens. This is especially true as new research shows targeted modifications of the immune response or
immunotherapy holds great promise as an effective treatment option to control and eradicate various tumors, for
the treatment and mitigation of antibiotic or antiviral resistant infectious diseases, and for the prevention of
chronic inflammatory diseases, etc.
Diverse research into aspects of immunology, host pathogen interactions, and the immunopathology
associated with an abnormal immune response is an important priority at LSU Health Sciences Center
Shreveport (LSUHSC-S) within multiple centers and departments. Immunology as a discipline can effectively
bridge many centers and departments currently on campus and thus serve as a nucleus for collaborative and
synergistic research across diverse disciplines. Immunology as a discipline is now at the forefront of novel
therapies to control bacterial infections, viral infections, to treat cancer; thus an expansion and growth of this
area at LSUHSC-S will advance the mission of the school to grow basic science that has strong translational
potential. The objective of this new COBRE Center for Applied Immunology and Pathological Processes
(CAIPP) to establish an independent internationally recognized research and training program at
LSUHSC-S. We propose to first mentor and develop federally funded junior faculty research and to develop
new infrastructure to support the growth and continued hiring in this important area of biomedical science.
Because Dr. Yurochko has 35 years of experience in immunology research, has been a junior PI in a COBRE
center, Project Mentor for successful projects and part of a COBRE leadership team, he can draw on a wealth
of experiences, along with those of the experienced leadership team, to drive the success of the CAIPP. Second,
we propose long term to retain these immunology researchers as they become more senior through promotion,
to become an international recognized research hub and to elevate the CAIPP within LSUHSC-S by becoming
a state recognized Center. We shall take advantage of the strengths currently on campus and through targeted
recruitment to grow the CAIPP COBRE around the focused understanding of “aberrant immune cell function and
the resulting immunopathology”. The cores address critical research needs on campus and are ultimately
essential for the long-term growth and status of research at LSUHSC-S. The cores build upon existing equipment
and infrastructure and bring new expertise not currently available on campus; thus, they fill a needed gap in
research infrastructure. Recent polling of the faculty document that all centers and most faculty (>80%) on
campus will utilize/require both proposed cores to generate the needed new data for competitive national grant
submissions. In summary, the major goals of this CAIPP COBRE application are to: establish a strong and
consistent mentorship and professional development program that meet the individual needs of each investigator
(and thus are tailored for the needs of that investigator); establish advanced research core facilities that support
the university, the region and the state; advance the mechanistic and clinical understanding for how subversion
of the immune response and functioning of immune cells influences human health and disease; and lastly to
create an academically and financially independent and internationally recognized Center of Excellence. We
support these major goals through our initial collaboration within centers and departments within the school and
the entire northern region of the state and to then grow this collaboration through engagement and collaborations
with colleagues in the rest of the state once we have established the foundation of the proposed CAIPP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10090769
-
项目类别:
-
资助金额:$43.8万
-
财政年份:2021
-
负责人:ANDREW D YUROCHKO
-
依托单位:
Center for Applied Immunology and Pathological Processes
-
批准号:10090768
-
项目类别:
-
资助金额:$215.04万
-
财政年份:2021
-
负责人:ANDREW D YUROCHKO
-
依托单位:
Administrative Core
-
批准号:10569051
-
项目类别:
-
资助金额:$57.83万
-
财政年份:2021
-
负责人:ANDREW D YUROCHKO
-
依托单位:
Center for Applied Immunology and Pathological Processes
-
批准号:10360457
-
项目类别:
-
资助金额:$216.01万
-
财政年份:2021
-
负责人:ANDREW D YUROCHKO
-
依托单位:
Administrative Core
-
批准号:10360458
-
项目类别:
-
资助金额:$39.81万
-
财政年份:2021
-
负责人:ANDREW D YUROCHKO
-
依托单位:
HCMV regulation of host cell signaling and cytokines in myelosuppression
-
批准号:9980285
-
项目类别:
-
资助金额:$21.29万
-
财政年份:2017
-
负责人:ANDREW D YUROCHKO
-
依托单位:
HCMV regulation of host cell signaling and cytokines in myelosuppression
-
批准号:10216638
-
项目类别:
-
资助金额:$26.8万
-
财政年份:2017
-
负责人:ANDREW D YUROCHKO
-
依托单位:
HCMV regulation of monocyte/macrophage host cell signaling in viral reactivation
-
批准号:10327952
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2017
-
负责人:ANDREW D YUROCHKO
-
依托单位:
HCMV regulation of monocyte/macrophage host cell signaling in viral reactivation
-
批准号:10629186
-
项目类别:
-
资助金额:$38.16万
-
财政年份:2017
-
负责人:ANDREW D YUROCHKO
-
依托单位:
LSUHSC COBRE:ENDOTHELIAL CELL PROLIFERATION DURING HCMV INFECTION
-
批准号:7171198
-
项目类别:
-
资助金额:$26.07万
-
财政年份:2005
-
负责人:ANDREW D YUROCHKO
-
依托单位:
Analysis of HCMV Infection of Monocytes and Macrophages
-
批准号:7731880
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2004
-
负责人:ANDREW D YUROCHKO
-
依托单位:
LSUHSC COBRE:ENDOTHELIAL CELL PROLIFERATION DURING HCMV INFECTION
-
批准号:6981872
-
项目类别:
-
资助金额:$27.2万
-
财政年份:2004
-
负责人:ANDREW D YUROCHKO
-
依托单位:
Analysis of HCMV Infection of Monocytes and Macrophages
-
批准号:6878033
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2004
-
负责人:ANDREW D YUROCHKO
-
依托单位:
Analysis of HCMV Infection of Monocytes and Macrophages
-
批准号:7216833
-
项目类别:
-
资助金额:$27.5万
-
财政年份:2004
-
负责人:ANDREW D YUROCHKO
-
依托单位:
Analysis of HCMV Infection of Monocytes and Macrophages
-
批准号:7918920
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2004
-
负责人:ANDREW D YUROCHKO
-
依托单位:
Analysis of HCMV Infection of Monocytes and Macrophages
-
批准号:8507128
-
项目类别:
-
资助金额:$33.74万
-
财政年份:2004
-
负责人:ANDREW D YUROCHKO
-
依托单位:
Analysis of HCMV Infection of Monocytes and Macrophages
-
批准号:7035276
-
项目类别:
-
资助金额:$28.32万
-
财政年份:2004
-
负责人:ANDREW D YUROCHKO
-
依托单位:
Analysis of HCMV Infection of Monocytes and Macrophages
-
批准号:8306977
-
项目类别:
-
资助金额:$35.9万
-
财政年份:2004
-
负责人:ANDREW D YUROCHKO
-
依托单位:
Analysis of HCMV Infection of Monocytes and Macrophages
-
批准号:9193053
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2004
-
负责人:ANDREW D YUROCHKO
-
依托单位:
Analysis of HCMV Infection of Monocytes and Macrophages
-
批准号:6774523
-
项目类别:
-
资助金额:$28.33万
-
财政年份:2004
-
负责人:ANDREW D YUROCHKO
-
依托单位:
海外基金